Decreased serum brain-derived neurotrophic factor levels in elderly Korean with dementia

Psychiatry Investigation

Volumn 6, Issue 4, 2009, Pages 299-305

  Jung, Goo Lee ^a   Bae, Sub Shin ^b   Young, Sun You ^c   Ji, Eun Kim ^d   Sung, Wook Yoon ^e   Dong, Wook Jeon ^e   Jun, Hyung Baek ^e   Sung, Woo Park ^a   Young, Hoon Kim ^a  

^a Inje University   (South Korea)

^b Department of Psychiatry   (South Korea)

^c Department of Psychiatry   (South Korea)

^d Dong Suh Mental Hospital   (South Korea)

^e Inje University College of Medicine   (South Korea)

Author keywords

Alzheimer's disease; Brain derived neurotrophic factor; Depression; Mild cognitive impairment

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; PROTEIN BLOOD LEVEL;

EID: 75649087374     PISSN: 17383684     EISSN: None     Source Type: Journal    
DOI: 10.4306/pi.2009.6.4.299     Document Type: Article

References (55)

1. Dugu M, Neugroschl J, Sewell M, Marin D. Review of dementia. Mt Sinai J Med 2003;70:45-53.
2. Cotter VT. The burden of dementia. Am J Manag Care 2007;13 Suppl 8:S193-S197.
3. Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260.
4. Blasko I, Grubeck-Loebenstein B. Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer's disease. Drugs Aging 2003;20:101-113.
5. Gorelick PB. Risk factors for vascular dementia and Alzheimer disease. Stroke 200435(11 Suppl 1):2620-2622.
6. Kunugi H, Ueki A, Otsuka M, Isse K, Hirasawa H, Kato N, et al. A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer's disease. Mol Psychiatry 2001;6:83-86.
7. Fahnestock M, Garzon D, Holsinger RM, Michalski B. Neurotrophic factors and Alzheimer's disease: are we focusing on the wrong molecule? J Neural Transm suppl 2002:241-252.
8. Riemenschneider M, Schwarz S, Wagenpfeil S, Diehl J, Müller U, Förstl H, et al. A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the apolipoprotein E epsilon4 allele. Mol Psychiatry 2002;7:782-785.
9. Ventriglia M, Bocchio Chiavetto L, Benussi L, Binetti G, Zanetti O, Riva MA, et al. Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's disease. Mol Psychiatry 2002;7:136-137.
10. Hashimoto R, Hirata Y, Asada T, Yamashita F, Nemoto K, Mori T, et al. Effect of the brain-derived neurotrophic factor and the apolipoprotein E polymorphisms on disease progression in preclinical Alzheimer's disease. Genes Brain Behav 2009;8:43-52.
11. Hashimoto R, Moriguchi Y, Yamashita F, Mori T, Nemoto K, Okada T, et al. Dose-dependent effect of the Val66Met polymorphism of the brain-derived neurotrophic factor gene on memory-related hippocampal activity. Neurosci Res 2008;61:360-367.
12. Hock C, Heese K, Hulette C, Rosenberg C, Otten U. Region-specific neurotrophin imbalances in alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas. Arch Neurol 2000;57:846-851.
13. Holsinger RM, Schnarr J, Henry P, Castelo VT, Fahnestock M. Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease. Brain Res Mol Brain Res 2000;76:347-354.
14. Laske C, Stransky E, Leyhe T, Esch weiler GW, Wittorf A, Richartz E, et al. Stage-dependent BDNF serum concentrations in Alzheimer's disease. J Neural Transm 2006;113:1217-1224.
15. Yasutake C, Kuroda K, Yanagawa T, Okamura T, Yoneda H. Serum BDNF, TNF-alpha and IL-1beta levels in dementia patients: comparison between Alzheimer's disease and vascular dementia. Eur Arch Psychiatry Clin Neurosci 2006;256:402-106.
16. Gunstad J, Benitez A, Smith J, Glickman E, Spitznagel MB, Alexander T, et al. Serum brain-derived neurotrophic factor is associated with cognitive function in healthy older adults. J Geriatr Psychiatry Neurol 2008;21:166-170.
17. Yu H, Zhang Z, Shi Y, Bai F, Xie C, Qian Y, et al. Association study of the decreased serum BDNF concentrations in amnestic mild cognitive impairment and the Val66Met polymorphism in Chinese Han. J Clin Psychiatry 2008;69:1104-1111.
18. Leyhe T, Stransky E, Eschweiler GW, Buchkremer G, Laske C. Increase of BDNF serum concentration during donepezil treatment of patients with early Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci 2008;258:124-128.
19. Leyhe T, Eschweiler GW, Stransky E, Gasser T, Annas P, Basun H, et al. Increase of BDNF serum concentration in lithium treated patients with early Alzheimer's disease. J Alzheimers Dis 2009;16:649-656.
20. Thoenen H. Neurotrophins and neuronal plasticity. Science 1995;270:593-598.
21. Lewin GR, Barde YA. Physiology of the neurotrophins. Annu Rev Neurosci 1996;19:289-317.
22. Migliorelli R, Teson A, Sabe L, Petracchi M, Leiguarda R, Starkstein SE. Prevalence and correlates of dysthymia and major depression among patients with Alzheimer's disease. Am J Psychiatry 1995;152:37-44.
23. Reichman WE, Coyne AC. Depressive symptoms in Alzheimer's disease and multi-infarct dementia. J Geriatr Psychiatry Neurol 1995;8:96-99.
24. Tueth MJ. How to manage depression and psychosis in Alzheimer's disease. Geriatrics 1995;50:43-46.
25. Reifler BV, Larson E, Hanley R. Coexistence of cognitive impairment and depression in geriatric outpatients. Am J Psychiatry 1982;139:623-626.
26. Breen AR, Larson EB, Reifler BV, Vitaliano PP, Lawrence GL. Cognitive performance and functional competence in coexisting dementia and depression. J Am Geriatr Soc 1984;32:132-137.
27. Pearson JL, Teri L, Reifler BV, Raskind MA. Functional status and cognitive impairment in Alzheimer's patients with and without depression. J Am Geriatr Soc 1989;37:1117-1121.
28. Laske C, Stransky E, Esch weiler G, Wittorf A, Richartz-Salzburger E, Bartels M, et al. BDNF serum concentrations in patients with Alzheimer's disease are associated with depressive mood states. Neurol Psychiatr Brain Res 2005;12:1-4.
29. Mckhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NlNCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
30. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Text revision. Washington DC: American Psychiatric Association; 2000.
31. Lee JH, Lee KU, Lee DY, Kim KW, Jhoo JH, Kim JH, et al. Development of the Korean version of the Consortium to Establish a Registry for Alzheimer's Disease Assessment Packet (CERAD-K): clinical and neuropsychological assessment batteries. J Gerontol B Psychol Sci Soc Sci 2002;57:47-53.
32. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414.
33. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-308.
34. Choi SH, Na DL, Lee BH, Hahn DS, Jeong JH, Yoon SJ, et al. Estimating the validity of Korean version of expanded Clinical Dementia Rating (CDR) scale. J Korean Neurol Assoc 2001;19:585-591.
35. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982-1983;17:37-49.
36. Cho MJ, Bae JN, Suh GH, Hahm BJ, Kim JK, Lee DW, et al. Validation of geriatric depression scale, Korean version (GDS) in the assessment of DSM-III-R major depression. J Korean Neuropsychiatr Assoc 1999;38:48-63.
37. Poduslo JF, Curran GL. Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF. Brain Res Mol Brain Res 1996;36:280-286.
38. Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 1998;37:1553-1561.
39. Karege F, Schwald M, Cisse M. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett 2002;328:261-264.
40. Mattson MP, Maudsley S, Martin B. BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci 2004;27:589-594.
41. Connor B, Young D, Yan Q, Faull RL, Synek B, Dragunow M. Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Brain Res Mol Brain Res 1997;49:71-81.
42. Ferrer I, Marin C, Rey MJ, Ribalta T, Goutan E, Blanco R, et al. BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies. J Neuropathol Exp Neurol 1999;58:729-739.
43. Lindvall O, Emfors P, Bengzon J, Kokaia Z, Smith ML, Siesjö BK, et al. Differential regulation of mRNAs for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the adult rat brain following cerebral ischemia and hypoglycemic coma. Proc Natl Acad Sci USA 1992;89:648-652.
44. Kokaia Z, Nawa H, Uchino H, Elmér E, Kokaia M, Carnahan J, et al. Regional brain-derived neurotrophic factor mRNA and protein levels following transient forebrain ischemia in the rat Brain Res Mol Brain Res 1996;38:139-144.
45. Miyake K, Yamamoto W, Tadokoro M, Takagi N, Sasakawa K, Nitta A, et al. Alterations in hippocampal GAP-43, BDNF, and L1 following sustained cerebral ischemia. Brain Res 2002;935:24-31.
46. Crutcher KA, Scott SA, Liang S, Everson WV, Weingartner J. Detection of NGF-like activity in human brain tissue: increased levels in Alzheimer's disease. J Neurosci 1993;13:2540-2550.
47. Lyketsos CG, Steele C, Baker L, Galik E, Kopunek S, Steinberg M, et al. Major and minor depression in Alzheimer's disease: prevalence and impact. J Neuropsychiatry Clin Neurosci 1997;9:556-561.
48. Green RC, Cupples LA, Kurz A, Auerbach S, Go R, Sadovnick D, et al. Depression as a risk factor for Alzheimer disease: The MIRAGE study. Arch Neurol 2003;60:753-759.
49. Gabryelewicz T, Styczynska M, Luczywek E, Barczak A, Pfeffer A, Androsiuk W, et al. The rate of conversion of mild cognitive impairment to dementia: predictive role of depression. Int J Geriatr Psychiatry 2007;22:563-567.
50. Rubin EH, Kinscherf DA, Grant EA, Storandt M. The influence of major depression on clinical and psychometric assessment of senile dementia of the Alzheimer type. Am J Psychiatry 1991;148:1164-1171.
51. Poon LW. Toward an understanding of cognitive functioning in geriatric depression. Int Psychogeriatr 1992;4 Suppl 2:241-266.
52. Forsell Y, Jorm AF, Winblad B. Association of age, sex, cognitive dysfunction, and disability with major depressive symptoms in an elderly sample. Am J Psychiatry 1994;151:1600-1604.
53. Zubenko GS, Moossy J, Kopp U. Neurochemical correlates of major depression in primary dementia. Arch Neurol 1990;47:209-214.
54. Lazarus LW, Newton N, Cohler B, Lesser J, Schweon C. Frequency and presentation of depressive symptoms in patients with primary degenerative dementia. Am J Psychiatry 1987;144:41-45.
55. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 2002;109:143-148.